Mankyu Park
Directeur/Bestuurslid bij Coagulant Therapeutics, Inc.
Profiel
Mankyu is a Principal at DTCP in the Growth Equity team and covers Korea-based investments.
Mankyu came to DTCP from L&S Venture Capital, a leading Korean VC specializing in IT, semiconductors, and display investments.
Prior to that he held positions in the investment banking division of KB Securities and at Partners Group.
Mankyu made investments in IT, AI, Bio/Life science, mobile platforms, and other tech sectors.
Mankyu also led a couple of mid-to-large size deals like Youngin Engineering and Coagulant Therapeutics where top-tier Korean local VCs participated.
Mankyu holds a bachelor’s degree in business administration with concentration on finance from Goizueta Business School, Emory University.
Actieve functies van Mankyu Park
| Bedrijven | Functie | Begin |
|---|---|---|
Coagulant Therapeutics, Inc.
 Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Coagulant Therapeutics, Inc. is a privately held company that focuses on designing, developing, and commercializing therapeutics for the coagulation cascade and its adjacencies. Coagulant Therapeutics is based in Berkeley, CA. The company's lead product candidate, CT-001, is a next-generation Factor VIIa designed for enhanced efficacy and safety in the setting of acute bleeding. The company is also developing additional therapeutics targeted to APC for the treatment of acute bleeding and other coagulation cascade-related diseases. The company was founded in 2019 by Terry Hermiston, who has been the CEO since then. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mankyu Park
| Bedrijven | Functie | Einde |
|---|---|---|
| DTCP Management GmbH | Corporate Officer/Principal | - |
Opleiding van Mankyu Park
| Goizueta Business School-Emory | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Coagulant Therapeutics, Inc.
Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Coagulant Therapeutics, Inc. is a privately held company that focuses on designing, developing, and commercializing therapeutics for the coagulation cascade and its adjacencies. Coagulant Therapeutics is based in Berkeley, CA. The company's lead product candidate, CT-001, is a next-generation Factor VIIa designed for enhanced efficacy and safety in the setting of acute bleeding. The company is also developing additional therapeutics targeted to APC for the treatment of acute bleeding and other coagulation cascade-related diseases. The company was founded in 2019 by Terry Hermiston, who has been the CEO since then. | Health Technology |
| DTCP Management GmbH | Finance |
